The mu opioid receptor (MOR) is a G protein-coupled receptor (GPCR) and is responsible for the effects of all medically used ... A recent development in opioid pharmacology has been the discovery of ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a ...

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala SE- 751 24, Sweden Department of Synthesis and Chemical Technology of Pharmaceutical Substances with ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

About GABAB Activation with PAM: Activation of gamma-aminobutyric acid subtype B (GABAB) receptor, a Family C class of GPCR ... of novel small molecule allosteric modulators for neurological ...

Addex Therapeutics partner Indivior advances GABAB positive allosteric modulator programme successfully through IND enabling studies: Geneva, Switzerland Tuesday, May 13, 2025, 15 ...

About GABAB Activation with PAM: Activation of gamma-aminobutyric acid subtype B (GABAB) receptor, a Family C class of GPCR, is clinically and commercially validated ... company focused on developing ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio ...